PolyPeptide Group AG
SIX:PPGN
PolyPeptide Group AG
SIX:PPGN
Price:
27.3
CHF
2.82%
Market Closed
Market Cap:
CHf904.4m
PolyPeptide Group AG
Other Items
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
PolyPeptide Group AG
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
PolyPeptide Group AG
SIX:PPGN
|
Other Items
-€4.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bachem Holding AG
SIX:BANB
|
Other Items
CHf92.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Siegfried Holding AG
SIX:SFZN
|
Other Items
-CHf9.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-139%
|
CAGR 10-Years
N/A
|
|
|
Lonza Group AG
SIX:LONN
|
Other Items
CHf654m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Tecan Group AG
SIX:TECN
|
Other Items
CHf97.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SKAN Group AG
SIX:SKAN
|
Other Items
-CHf15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
PolyPeptide Group AG
Glance View
PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.
PPGN
Intrinsic Value
23.23
CHF
Overvaluation 15%
See Also
What is PolyPeptide Group AG's Other Items?
Other Items
-4.1m
EUR
-4.1m
EUR
Based on the financial report for Dec 31, 2024, PolyPeptide Group AG's Other Items amounts to -4.1m EUR.
What is PolyPeptide Group AG's Other Items growth rate?
Other Items CAGR 3Y
-9%
-9%
Over the last year, the Other Items growth was -46%. The average annual Other Items growth rates for PolyPeptide Group AG have been -9% over the past three years .
